Closed sjspielman closed 1 year ago
@jharenza I wonder if you could weigh in on something really quickly - I'm going through all of these (almost done!!) to see if trends identified in the MS are broadly consistent after tumor purity filtering (preview: so far consistent!).
But, I realize our wording in this MS sentence might need some clean-up in general since I'm not exactly sure what it's referring to: https://github.com/AlexsLemonade/OpenPBTA-manuscript/blob/b0fdf6f24fe9c021f22e8b7da348708f68877ee5/content/03.results.md?plain=1#L279
We also observed significant upregulation of pro-inflammatory cytokines IFN$\alpha$ and IFN$\gamma$ in LGGs and craniopharyngiomas compared to medulloblastoma and ependymoma tumors (Bonferroni-corrected p < 0.05), both of which showed significant down-regulation of these cytokines (Figure {@fig:Fig5}B).
Is this making a statement specifically about comparing LGG to MB (for example, and so on..), or a broad statement overall LGG comparisons, MB comparisons, etc to any other cancer group?
sure - this is saying: up in in LGG compared to MB up in LGG compared to EPN up in Cranio compared to MB up in cranio cpmpared to EPN
based on how i wrote it 😬
To assess the affects of tumor purity on our results, we should re-run GSVA, considering only samples that have
tumor_fraction>= median tumor fraction
(https://github.com/AlexsLemonade/OpenPBTA-analysis/pull/1622).We should then assess how well the following results hold up: